BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 14576096)

  • 1. Heterogeneity of macrolide-lincosamide-streptogramin B resistance phenotypes in enterococci.
    Min YH; Jeong JH; Choi YJ; Yun HJ; Lee K; Shim MJ; Kwak JH; Choi EC
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3415-20. PubMed ID: 14576096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.
    Giovanetti E; Montanari MP; Mingoia M; Varaldo PE
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1935-40. PubMed ID: 10428916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of macrolide-lincosamide-streptogramin B (MLS(B)) and telithromycin resistance in clinical strains of staphylococci].
    Saribaş Z; Tunçkanat F; Ozçakir O; Ercis S
    Mikrobiyol Bul; 2010 Apr; 44(2):177-86. PubMed ID: 20549951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo spread of macrolide-lincosamide-streptogramin B (MLSB) resistance--a model study in chickens.
    Marosevic D; Cervinkova D; Vlkova H; Videnska P; Babak V; Jaglic Z
    Vet Microbiol; 2014 Jul; 171(3-4):388-96. PubMed ID: 24467930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolide-lincosamide-streptogramin resistance phenotypes and genotypes of coagulase-positive Staphylococcus aureus and coagulase-negative staphylococcal isolates from bovine mastitis.
    Li L; Feng W; Zhang Z; Xue H; Zhao X
    BMC Vet Res; 2015 Jul; 11():168. PubMed ID: 26209340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide-lincosamide-streptogramin B resistance phenotypes and genotypes among Staphylococcus aureus clinical isolates in Japan.
    Otsuka T; Zaraket H; Takano T; Saito K; Dohmae S; Higuchi W; Yamamoto T
    Clin Microbiol Infect; 2007 Mar; 13(3):325-7. PubMed ID: 17391391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin.
    Yao W; Xu G; Li D; Bai B; Wang H; Cheng H; Zheng J; Sun X; Lin Z; Deng Q; Yu Z
    BMC Infect Dis; 2019 Feb; 19(1):175. PubMed ID: 30782125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of resistance to macrolide, lincosamide and streptogramin antibiotics in Gram-positive cocci isolated in a Korean hospital.
    Lim JA; Kwon AR; Kim SK; Chong Y; Lee K; Choi EC
    J Antimicrob Chemother; 2002 Mar; 49(3):489-95. PubMed ID: 11864949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foggy D-shaped zone of inhibition in Staphylococcus aureus owing to a dual character of both inducible and constitutive resistance to macrolide-lincosamide-streptogramin B.
    Yoon EJ; Kwon AR; Min YH; Choi EC
    J Antimicrob Chemother; 2008 Mar; 61(3):533-40. PubMed ID: 18230691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide-lincosamide-streptogramin B (MLS) resistance in cutaneous propionibacteria: definition of phenotypes.
    Eady EA; Ross JI; Cove JH; Holland KT; Cunliffe WJ
    J Antimicrob Chemother; 1989 Apr; 23(4):493-502. PubMed ID: 2501269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.
    Montanari MP; Mingoia M; Giovanetti E; Varaldo PE
    J Clin Microbiol; 2001 Apr; 39(4):1311-5. PubMed ID: 11283047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of macrolide, lincosamide and streptogramin B resistance in Staphylococcus aureus strains isolated from clinical samples by phenotypical and genotypical methods].
    Aydeniz Ozansoy F; Cevahir N; Kaleli İ
    Mikrobiyol Bul; 2015 Jan; 49(1):1-14. PubMed ID: 25706726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of resistance phenotypes and genotypes to macrolide, lincosamide and streptogramin antibiotics in Gram-positive cocci isolated in Tunisian Bone Marrow Transplant Center.
    Bouchami O; Achour W; Ben Hassen A
    Pathol Biol (Paris); 2011 Aug; 59(4):199-206. PubMed ID: 19481372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution, characterization and genetic bases of erythromycin resistance in staphylococci and enterococci originating from livestock.
    Jaglic Z; Vlkova H; Bardon J; Michu E; Cervinkova D; Babak V
    Zoonoses Public Health; 2012 May; 59(3):202-11. PubMed ID: 21843202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and genotypic study of macrolide, lincosamide and streptogramin B (MLSB) resistance in clinical isolates of Staphylococcus aureus in Tehran, Iran.
    Saderi H; Emadi B; Owlia P
    Med Sci Monit; 2011 Feb; 17(2):BR48-53. PubMed ID: 21278685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Enterococcus faecium with macrolide resistance and reduced susceptibility to quinupristin/dalfopristin in a Japanese hospital: detection of extensive diversity in erm(B)-regulator regions.
    Isogai N; Urushibara N; Kawaguchiya M; Ghosh S; Suzaki K; Watanabe N; Quiñones D; Kobayashi N
    Microb Drug Resist; 2013 Aug; 19(4):298-307. PubMed ID: 23442208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Macrolide-Lincosamide-Streptogramin B Resistance Gene
    Wipf JRK; Riley MC; Kania SA; Bemis DA; Andreis S; Schwendener S; Perreten V
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
    Bejuk D
    Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.
    Bemer-Melchior P; Juvin ME; Tassin S; Bryskier A; Schito GC; Drugeon HB
    Antimicrob Agents Chemother; 2000 Nov; 44(11):2999-3002. PubMed ID: 11036012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.